期刊文献+

广西99例AIDS患者经高效抗逆转录病毒治疗后脂代谢的初步研究 被引量:1

A preliminary study on lipid metabolism of 99 AIDS patients under highly active antiretroviral therapy
原文传递
导出
摘要 目的了解艾滋病(acquired immunodeficiency syndrome,AIDS)患者经高效抗逆转录病毒治疗(highly active antiretroviral therapy,HAART)后体脂肪的代谢情况。方法采用生物电阻抗法对99例经HAART治疗的AIDS患者进行体成分定量测定,用偏相关分析了解总体脂肪量与各部位脂肪量的关系,通过建立多重线性回归方程对脂肪量进行预测。结果男女患者的总脂肪量、皮下、躯干和四肢脂肪含量差异均有统计学意义(均有P<0.05)。偏相关分析显示,AIDS患者的总脂肪量与内脏脂肪量、皮下脂肪量及右上肢脂肪量均呈正相关(均有P<0.05)。多重线性回归分析结果显示,总脂肪量与皮下脂肪量、内脏脂肪量及体重关系密切。结论本研究获得了广西AIDS患者体脂肪的基线资料,可为开展AIDS病人脂代谢的防控等提供科学依据。 Objective To understand the alteration of lipid metabolism in AIDS patients under highly active antiretroviral therapy (HAART). Methods Body compositions of 99 AIDS patients were quantitatively measured by bioelectrical impedance analysis. The relationship between total fat mass and fat mass in different parts of the body were analyzed by partial correlation analysis, and multiple linear regression models were built to predict total fat mass. Results There were significant differences in total fat mass, subcutaneous fat mass, trunk mass and four limbs fat mass between male and female patients ( all P 〈 0. 05 ). Partial correlation analysis revealed that AIDS patients' fat mass was positively related to their visceral and subcutaneous fat mass and right upper limb fat mass ( all P 〈 0. 05 ). Multiple linear regression analysis showed that total fat mass was related to subcutaneous and visceral fat mass and body weight. Conclusions This study has got the base-line information of body fat of Guangxi AIDS patients and it can provide scientific basis to carry out the research in prevention of abnormal the lipid metabolism of AIDS patients
出处 《中华疾病控制杂志》 CAS 北大核心 2013年第12期1046-1048,共3页 Chinese Journal of Disease Control & Prevention
基金 国家自然科学基金(31160222) 广西中医药大学附属瑞康医院课题(RKZ201004) 广西医科大学大学生创新课题(055)
关键词 获得性免疫缺陷综合征 脂肪类 能量代谢 Acquired immunodeficiency syndrome Fats Energy metabolism
  • 相关文献

参考文献12

  • 1Centers For Disease Control. Kaposis sarcoma and Pneumocystis pneumonia among homosexual men-New York city and California [J]. MMWR Morb Mortal Wkly Rep, 1981,30(25) :305-308.
  • 2王福春.我国艾滋病流行情况与防治对策[J].职业与健康,2011,27(21):2494-2496. 被引量:13
  • 3王夏,唐力,刘满清,姚中兆,吴斯,孙敏,姚璇,周旺.武汉市艾滋病病人高效抗逆转录病毒治疗效果分析[J].中华疾病控制杂志,2010,14(3):212-214. 被引量:18
  • 4许云亚,吴欣华,蒙艳,李楠微.抗反转录病毒治疗HIV/AIDS初治患者232例结果分析[J].昆明医学院学报,2011,32(3):89-92. 被引量:3
  • 5中华医学会感染学分会艾滋病学组.艾滋病诊疗指南(2011版)[K].2011.
  • 6王鹏飞,焦艳梅,朱焕章,吴昊.HIV/AIDS治疗研究进展[J].首都医科大学学报,2010,31(6):715-718. 被引量:4
  • 7Freitas P, Carvalho D, Souto S, et al. Impact of Lipodystophy on the prevalence and components of metabolic syndrome in HIV-in- fected patients [J]. BMC Infect Dis, 2011,11:246.
  • 8Lake JE, Wohl D, Scherzer R, et al. Regional fat deposition and cardiovascular risk in HIV infection : the FRAM study [ J ]. AIDS Care, 2011,23(8) :929-938.
  • 9Montessori V, Press N, Harris M, et al. Adverse effects of antiret- roviral therapy for HIV infection [ J ]. Can Med Assoc J, 2004, 170(2) :229-238.
  • 10Oka F, Naito T, Oike M, et al. Correlation between HIV disease and lipid metabolism in antiretroviral-na? ve HIV-infected pa- tients in Japan [ J]. J Infect Chemotber, 2012,18 ( 1 ) : 17-21.

二级参考文献50

  • 1汪宁.中国艾滋病流行现状与防治对策[J].社会福利(实务版),2005(10):29-31. 被引量:15
  • 2许桂锋,李波,张松梅,侯春霞,梁华龙.茂名市艾滋病流行现状及防制策略[J].疾病控制杂志,2006,10(1):92-93. 被引量:7
  • 3何卫华,周沛林,何华仙,张杨,黄希平,吴晓云,张绍兰.艾滋病病毒耐药性及其影响因素的研究[J].疾病控制杂志,2006,10(3):259-261. 被引量:8
  • 4区博文.江门市艾滋病自愿咨询检测工作现况[J].中国艾滋病性病,2007,13(3):275-275. 被引量:7
  • 5WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision) [DB/OL]. (2006-08-07)[2009-08-20]. http://www. who. int/hiv/pub/guidelines/artadultguidelines, pdf.
  • 6WHO. Important: addendum to 2006 WHO guidelines on antiretroviral therapy for HIV infection in adults and adolescents (2006) [ DB/OL ]. http://www, who. int/hiv/art/ARTadult-saddendum, pdf.
  • 7Ghani AC, Ferguson NM, Fraser C, et al. Viral replication under combination antiretroviral therapy: a comparison of four different regimens [J]. J Acquit Immune Defic Syndr, 2002,30 (2) : 167-176.
  • 8UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom [J]. BMJ, 2001, 322 : 1087-1088.
  • 9Little SJ. Transmission and prevalence of HIV resistance among treatment-naive subjects [J]. Antivir Ther, 2000,5( 1 ):33-40.
  • 10Li TS, Tubiana R, Katlama C, et al. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active an- ti'retrovlral therapy in advanced HIV-1 disease [J ]. Lancet, 1998,351(9117) : 1682-1686.

共引文献34

同被引文献19

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部